ARCHIVES

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

University Fires Bezwoda For Scientific Misconduct.

March 17, 2000